|Dr. Miguel Forte M.D., Ph.D.||CEO, MD & Exec. Director||347.75k||N/A||1960|
|Dr. Anne-Sophie Lebrun Ph.D.||Chief Operations Officer||N/A||N/A||1983|
|Dr. Anthony Ting Ph.D.||Chief Scientific Officer||N/A||N/A||1963|
|Gunther De Backer||Head of Corp. Communications & Investor Relations||N/A||N/A||N/A|
|Valerie Chapelle||Interim HR Director||N/A||N/A||N/A|
|Dr. Stefanos Theoharis Ph.D.||Chief Bus. Officer||N/A||N/A||1976|
|Dr. Anne Leselbaum M.D.||Chief Medical Officer||N/A||N/A||1966|
|Mr. Ching Man Choi||Bus. Devel. Mang.||N/A||N/A||N/A|
Bone Therapeutics SA, a biotechnology company, engages in the development of cell therapy products for orthopedics and bone diseases. Its products include ALLOB, an allogeneic cell therapy product, which is in Phase I/IIa clinical trial for the treatment of delayed-union fractures and lumbar spinal fusion; and JTA-004, an intra-articular injectable that is in phase III clinical trial to treat osteoarthritic pain in the knee. Bone Therapeutics SA was incorporated in 2006 and is based in Mont-Saint-Guibert, Belgium.
Bone Therapeutics SA’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.